DAA849 |
telomere shortening |
— |
— |
liver |
Human |
|
DAA989 |
telomere shortening |
— |
— |
lymphocytes |
Human |
|
DAA902 |
specific activities of enzymes are reduced |
— |
— |
kidney |
Human |
|
DAA959 |
telomere shortening |
— |
— |
naïve T cell |
Human |
|
DAA2056 |
MicroRNA let-7b expression upregulated |
— |
— |
skeletal muscle |
Human |
|
DAA901 |
telomere shortening |
— |
— |
kidney |
Human |
|
DAA1224 |
MTHFR methylation decrease |
— |
— |
prefrontal cortex |
Human |
|
DAA2057 |
MicroRNA let-7e expression upregulated |
— |
— |
skeletal muscle |
Human |
|
DAA1232 |
decreased proteasomal activity in T cells |
— |
— |
T cell |
Human |
|
DAA673 |
telomere length in hematopoietic stem cells |
— |
— |
hematopoietic stem cells |
Human |
|
DAA890 |
IgM deposition in glomeruli |
— |
— |
glomerulus |
Human |
|
DAA1231 |
decreased NF-KappaB induction in T cells |
— |
— |
T cell |
Human |
|
DAA1986 |
telomere shortening |
— |
— |
leukocyte |
Human |
|
DAA2042 |
Increase in IgA and IgM |
— |
— |
oral cavity |
Human |
|
DAA1998 |
Lipid oxidation increased with age in males |
— |
— |
skin |
Human |
|
DAA1211 |
blood HSP70 level increase |
— |
— |
plasma |
Human |
|
DAA877 |
Higher oxidation and decreased proteasome activity |
— |
— |
epidermis |
Human |
|
DAA1997 |
DNA damage increases with age |
— |
— |
skin |
Human |
|
DAA2038 |
Concentration of cell free DNA increases |
— |
— |
plasma |
Human |
|
DAA2047 |
creatinine levels increase |
— |
— |
plasma |
Human |
|
DAA2000 |
NAD(+) levels decrease with age |
— |
— |
skin |
Human |
|
DAA1065 |
efflux pump activity decreases |
— |
— |
blood brain barrier |
Human |
|
DAA2055 |
Circulating miR-21 expression increases |
— |
— |
blood |
Human |
|
DAA1067 |
transporter activity decreases |
— |
— |
blood brain barrier |
Human |
|
DAA4478 |
Gene expression of PLA2G4B increases with age |
PLA2G4B |
— |
skin |
Human |
|